Biogen Idec announces positive top-line results from Phase 3 study of peginterferon beta-1a in multiple sclerosis Biogen Idec, 24 Jan 2013 Accessed on 29 Jan 2013 from http://www.biogenidec.com/PRESS_RELEASE_DETAILS.aspx?ID=5981&ReqId=1777510. CommentRecommendBookmarkWatch